PerpEquities

Top analysts on stock perps · Analyst

Bradley Canino (Guggenheim): analyst track record on stock perps

Bradley Canino of Guggenheim on companies with stock perpetual futures: star rating, success rate, price-target accuracy, current calls and the measured perp reaction after each rating.

Stars4.3★
Success45%
Excess return+9.4%
rank#1,820
Ratings252
ratings on stock perps16

Track record

TipRanks data via FMP
12 months3 years
Ratings55207
Stock1824
Buy / hold / sell54 / 1 / 0183 / 24 / 0
Upgrades / downgrades / initiations0 / 1 / 71 / 3 / 26
Price targets hit / missed1 / 53 (2%)31 / 173 (15%)
Avg. return after a rating (TipRanks)-51.6%-43.9%
Best / worst call+16.4% / -82.7%+199.4% / -100.0%

After buy calls: not enough measured cases yet

Current calls on stock perps

StockCallTargetvs last closeDate
$SMMT Summit Therapeutics Inc.Buy · Reiterated$38.00+145.6%Jul 23, 2026

Recent ratings

  • Jul 23, 2026 $SMMT: Reiterated · Buy · $38.00 · article
  • Jun 1, 2026 $SMMT: Maintained · Buy · $40.00 · article
  • Apr 22, 2026 $SMMT: Reiterated · Buy · $40.00 · article
  • Feb 24, 2026 $SMMT: Maintained · Buy · $40.00 · article
  • Sep 3, 2025 $SMMT: Initiated · Buy · $40.00 · article
  • Mar 11, 2025 $SMMT: Maintained · Buy · $40.00 · article
  • Feb 24, 2025 $SMMT: Reiterated · Hold · $40.00 · article
  • Oct 31, 2024 $SMMT: Maintained · Buy · $40.00 · article
  • Oct 4, 2024 $SMMT: Maintained · Buy · $40.00 · article
  • Sep 25, 2024 $SMMT: Maintained · Buy · $40.00 · article
  • Sep 9, 2024 $SMMT: Maintained · Buy · $25.00 · article
  • Jun 3, 2024 $SMMT: Reiterated · Buy · $14.00 · article
  • May 24, 2024 $SMMT: Maintained · Buy · $8.00 · article
  • May 2, 2024 $SMMT: Maintained · Buy · $8.00 · article
  • Apr 11, 2024 $SMMT: Maintained · Buy · $8.00 · article
  • Mar 26, 2024 $SMMT: Initiated · Buy · $8.00 · article

Bradley Canino4.3★ · 45% success · +9.4% excess return · TipRanks data via FMP · Source headlines via TheFly/StreetInsider (FMP). Reaction = venue-median perp move after our detection — an observation, not investment advice.